37results about How to "High amount" patented technology

A temperature compensated frequency reference comprising first MEMS oscillator (MEMS1) used as frequency reference oscillator (REF) for phase locked loop, and means for temperature compensation of phase locked loop output frequency (Fout), wherein the phase locked loop comprises a second MEMS oscillator (MEMS2) used as electronically controlled oscillator (VCO) of phase locked loop.

A ballistic armor uses shape memory alloys and novel joining techniques to form a solution from a combination of shape memory metallic alloys (SMA) and ceramic materials. The SMA allows a high amount of strain to be recovered through a low temperature heat treatment. The amount of strain recoverable is much higher than that available through conventional thermal expansion mismatch solutions. Solid state or low temperature bonding methods are used to join the dissimilar materials. This joining technique avoids introducing excessive heat that would cause the SMA to transform before the armor system is assembled.

The present invention relates to a genetically modified Acinetobacter host for lipid production. The Acinetobacter host has been genetically modified to be deficient of one or more of genes A) a gene encoding fatty acyl-CoA reductase (EC1.2.1.n2), wherein said host is capable of increased production of TAGs and/or of total lipids compared to the parent host; and/or B) a gene encoding lipase (EC:3.1.1.3), a gene encoding pyruvate dehydrogenase (EC:1.2.2.2), and/or gene ACIAD 2177, or functional equivalents of any of said genes, wherein said host is capable of increased production of wax esters and/or total lipids compared to the parent host.

The present invention relates to highly reliable organic EL elements that can provide higher luminance with lower voltage and exhibit lower leak current at negative biases and appropriate diode properties. The organic EL element comprises a positive hole injecting layer, and a perfluoropolyether compound is incorporated into the positive hole injecting layer. Preferably, the perfluoropolyether compound is expressed by formula (1) or (2),

R¹—Rf—R²  formula (1)

Rf—R³  formula (2)

• • in which, R¹, R², and R³ represents one of a hydrogen atom, a fluorine atom, and a substituted group; Rf represents the perfluoropolyether skeleton expressed by the formula (3),
  • in which, R⁴ and R⁵ represent general formula —C_pF₂p+₁; n, m, x, and y are each an integer.

The present invention is in the field of manufacturing drug-loaded microparticles, and specifically provides processes for producing approximately homogenously sized drug loaded microparticles with high drug loading and reproducible drug release profiles, and which may be provided in a significantly reduced time period.

The invention discloses a preparation method of carboxylated acrylonitrile-butadiene latex for disposable gloves. The preparation method utilizes following raw materials: 30%-50% of butadiene, 10%-25%of methacrylic acid, 20%-30% of acrylonitrile, 15%-20% of a nonionic emulsifier, 5%-15% of deionized water, 1%-5% of a catalyst and 3%-5% of an antioxidant. According to the method, the butadiene, the methacrylic acid, the acrylonitrile and other raw materials are adopted for preparation, the reaction efficiency is high, high strength and small shrinkage are achieved, and the catalyst is preheated and subjected to heat preservation, so that the reaction efficiency is effectively improved, the temperature runaway phenomenon is avoided, the antioxidant is added in a candidate manner, the quality of a finished product is effectively improved, and the oxidative damage is reduced, so that the technological process can be greatly simplified, the control is facilitated, quality of the product isimproved, and popularization and application are facilitated.

The present invention relates to a mRNA comprising a nucleic acid sequence encoding a protein and a signal peptide and a transcription unit, an expression vector or a gene therapy vector comprising a nucleic acid encoding a protein and a signal peptide. Also disclosed herein is a therapeutic composition comprising said mRNA, transcription unit, expression vector or gene therapy vector and use of the therapeutic composition in treating a disease or a condition.

Disclosed is a thermoelectric device in which a separate interlayer is inserted between a thermoelectric leg and an electrode to reduce the contact resistance between the thermoelectric leg and the electrode, so that the interlayer serves as a tunneling path between the thermoelectric leg and the electrode, facilitating the charge movements between the two materials, and the thermoelectric device according to an embodiment includes a substrate, a thermoelectric leg positioned on the substrate, an interlayer positioned on the thermoelectric leg, and including a plurality of interlayer materials chemically bonded with the thermoelectric leg, and an electrode positioned on the interlayer, and electrically connected to the thermoelectric leg.